# To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)

> **NCT00957229** · PHASE2 · COMPLETED · sponsor: **UCSF Benioff Children's Hospital Oakland** · enrollment: 41 (actual)

## Conditions studied

- Basal Cell Nevus Syndrome
- Gorlin Syndrome

## Interventions

- **DRUG:** GDC-0449

## Key facts

- **NCT ID:** NCT00957229
- **Lead sponsor:** UCSF Benioff Children's Hospital Oakland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2021-01-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00957229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00957229, "To Determine The Efficacy and Safety of GDC-0449 in Patients With Basal Cell Nevus Syndrome (BCNS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00957229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*